What Ascend GmbH does

Ascend GmbH is a Frankfurt am Main-based pharmaceutical company and a 100% subsidiary of India's Alkem Laboratories Limited, founded in 2009. It operates as a B2B supplier of prescription generic medicines to pharmacies, hospitals, wholesalers, and distributors across Germany. The product portfolio spans more than 30 generic SKUs across cardiovascular (rivaroxaban, ticagrelor, olmesartan/amlodipine), neurology and psychiatry (pregabalin, lacosamide, gabapentin, aripiprazole, rasagiline), diabetes (sitagliptin, sitagliptin/metformin), urology (tamsulosin, solifenacin), immunosuppression (mycophenolate mofetil, tacrolimus), anti-infectives (cefuroxime, linezolid, fosfomycin), and specialty indications (everolimus, fingolimod, riluzole, tolvaptan, sodium oxybate). Products are delivered in multiple formulations including film-coated tablets, hard capsules, oral solutions, and granules.

The German entity itself is a lean commercial vehicle (5 employees), with manufacturing, API development, and bioequivalence research executed through Alkem's 21 facilities and 6 R&D centers, all operating to EU GMP, FDA, and TGA standards. Ascend's technology posture is anchored by Alkem's regulatory depth — over 140 FDA ANDA filings, nearly 60 TGA filings, and approximately 30 EU dossiers — which the company leverages to bring complex and differentiated generics to the German market. Beyond products, Ascend operates a differentiated 100% stock value loss reimbursement service for pharmacy and wholesale partners, addressing a structural pain point of the German reference-price system. Distribution runs through direct pharmacy and hospital relationships plus a wholesaler/distributor network, with B2B marketing conducted via a corporate website, HCP portal, industry events, and direct HCP communication channels.

Name

Ascend GmbH

Legal name

Ascend GmbH

Website

https://ascend-de.eu

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Ascend GmbH is a Frankfurt-based, 100% subsidiary of India's Alkem Laboratories that distributes a broad portfolio of prescription generic medicines to pharmacies, hospitals, and wholesalers across Germany across cardiovascular, neurology, diabetes, and other therapeutic areas.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Prescription medicines
• Generic drug manufacturing
• Pharmaceutical distribution
• Bioequivalence studies

Headquarters

HQ city

Frankfurt am Main

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Generic Pharmaceuticals Sales: Revenue generated from sale of prescription generic medicines to pharmacies and hospitals across Germany. The company supplies a broad product portfolio covering multiple therapeutic areas including cardiovascular, neurology, oncology, and metabolic disorders.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Ascend GmbH manufactures and distributes a broad portfolio of generic prescription medicines to pharmacies and hospitals across Germany. The product range spans multiple therapeutic areas including cardiovascular, neurology/psychiatry, diabetes, oncology, immunosuppression, anti-infectives, and urology, offered in formulations such as film-coated tablets, hard capsules, oral solutions, and granules. In addition, the company provides a Stock Value Loss Reimbursement Service offering 100% coverage of stock value losses for pharmacy and wholesale partners.

Product overview

Ascend GmbH is a German pharmaceutical company and 100% subsidiary of Alkem Laboratories Limited that operates as a leading manufacturer and distributor of generic prescription medicines in Germany. The company offers a broad portfolio of generic pharmaceuticals across multiple therapy areas including cardiovascular (rivaroxaban, ticagrelor, olmesartan/amlodipin), neurology/psychiatry (pregabalin, lacosamid, gabapentin, rasagilin, aripiprazol), diabetes (sitagliptin, sitagliptin/metformin), urology (tamsulosin, solifenacin), immunosuppression (mycophenolate mofetil, tacrolimus), anti-infectives (cefuroxim, linezolid, fosfomycin), and other specialties (tolvaptan, everolimus, fingolimod, riluzol, cinacalcet, colesevelam, finasterid, eslicarbazepin, sodium oxybate). Products are available in various formulations including film-coated tablets, hard capsules, oral solutions, and granules. In addition to its pharmaceutical portfolio, Ascend Germany provides a stock value loss reimbursement service offering 100% coverage of stock value losses for pharmacy partners. The company leverages R&D capabilities through its parent company Alkem Laboratories, which operates EU GMP, TGA, and FDA-approved manufacturing facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• ARIPIPRAZOL Ascend Tablets Generic aripiprazole tablets for the treatment of schizophrenia and related conditions.
• CEFUROXIM Ascend Film-coated Tablets Generic cefuroxime film-coated tablets, an antibiotic for treating bacterial infections.
• CINACALCET Ascend Film-coated Tablets Generic cinacalcet film-coated tablets for the treatment of secondary hyperparathyroidism.
• COLESEVELAMHYDROCHLORIDE Ascend Film-coated Tablets Generic colesevelam film-coated tablets for cholesterol management.
• ESLICARBAZEPIN Ascend Tablets Generic eslicarbazepine acetate tablets for epilepsy treatment.
• EVEROLIMUS Ascend Tablets Generic everolimus tablets used in oncology and transplant medicine.
• EZETIMIB Ascend Tablets Generic ezetimibe tablets for cholesterol absorption inhibition.
• EZETIMIB/Simvastatin Ascend Tablets Combined generic ezetimibe and simvastatin tablets for cholesterol management.
• FINASTERID Ascend Film-coated Tablets Generic finasteride film-coated tablets for benign prostatic hyperplasia and male pattern hair loss.
• FINGOLIMOD Ascend Hard-capsules Generic fingolimod hard capsules for multiple sclerosis treatment.
• FOSFOMYCIN Ascend Granules for preparation of an oral solution Generic fosfomycin granules for preparing an oral solution, an antibiotic for urinary tract infections.
• GABAPENTIN Ascend Film-coated Tablets Generic gabapentin film-coated tablets for epilepsy and neuropathic pain.
• GABAPENTIN Ascend Hard-capsules Generic gabapentin hard capsules for epilepsy and neuropathic pain treatment.
• LACOSAMID Ascend Film-coated Tablets Generic lacosamide film-coated tablets for epilepsy treatment.
• LACOSAMID Ascend Syrup Generic lacosamide syrup formulation for epilepsy treatment.
• LINEZOLID Ascend Film-coated Tablets Generic linezolid film-coated tablets, an antibiotic for serious infections.
• MYCOPHENOLATMOFETIL Ascend Film-coated Tablets Generic mycophenolate mofetil film-coated tablets for immunosuppression after organ transplantation.
• MYCOPHENOLATMOFETIL Ascend Hard-capsules Generic mycophenolate mofetil hard capsules for immunosuppression.
• NATRIUMOXYBAT Ascend Oral Solution Generic sodium oxybate oral solution for narcolepsy treatment.
• OLMESARTAN Medoxomil/Amlodipin Ascend Combined generic olmesartan medoxomil and amlodipine tablets for hypertension treatment.
• PREGABALIN Ascend Hard-capsules Generic pregabalin hard capsules for epilepsy, neuropathic pain, and anxiety disorders.
• PREGABALIN Ascend Oral Solution Generic pregabalin oral solution for the same indications as the capsule form.
• RASAGILIN Ascend Tablets Generic rasagiline tablets for Parkinson's disease treatment.
• RILUZOL Alkem Film-coated Tablets Generic riluzole film-coated tablets for amyotrophic lateral sclerosis (ALS) treatment.
• RIVAROXABAN Ascend Film-coated Tablets Generic rivaroxaban film-coated tablets, an anticoagulant for preventing blood clots.
• SITAGLIPTIN Ascend Film-coated Tablets Generic sitagliptin film-coated tablets for type 2 diabetes treatment.
• SITAGLIPTIN & METFORMINHYDROCHLORID Ascend Film-coated Tablets Combined generic sitagliptin and metformin film-coated tablets for type 2 diabetes.
• SOLIFENACINSUCCINAT Film-coated Tablets Generic solifenacin succinate film-coated tablets for overactive bladder treatment.
• TACROLIMUS Ascend Hard-capsules Generic tacrolimus hard capsules for immunosuppression after organ transplantation.
• TAMSULOSIN Ascend Hard-capsules with modified release Generic tamsulosin hard capsules with modified release for benign prostatic hyperplasia.
• TICAGRELOR Ascend Film-coated Tablets Generic ticagrelor film-coated tablets, an antiplatelet agent for acute coronary syndrome.
• TOLVAPTAN Ascend Tablets Generic tolvaptan tablets for hyponatremia and autosomal dominant polycystic kidney disease.
• Stock Value Loss Reimbursement Service A self-service tool providing 100% reimbursement of stock value losses for pharmacy and wholesale partners.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Alkem Laboratories LimitedcoreStrategic or Co-development PartnerAlkem Laboratories Limited (India) is the parent company of Ascend GmbH, holding 100% ownership. Alkem provides research and development capabilities, manufacturing facilities, and product portfolio access. Alkem has filed over 140 ANDAs with the US FDA, nearly 60 products with Australian TGA, approximately 30 for the EU, and many dossiers in other countries. The partnership enables Ascend to provide innovative generic formulations and off-patent generics to patients in Germany.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Stada Arzneimittel AG: One of Germany's largest generic pharmaceutical manufacturers with a broad portfolio across cardiovascular, neurology, and other therapeutic areas. Directly comparable to Ascend in target customers (pharmacies, hospitals) and product type (off-patent generics), but with substantially larger scale and a broader international footprint.
• Mylan Germany (Viatris): German arm of global generic and specialty pharmaceutical group Viatris. Operates in the same B2B pharmacy and hospital channel as Ascend with an overlapping portfolio of off-patent prescription generics across cardiovascular, CNS, and other therapeutic areas.

Direct peers

• Hexal AG: Germany's leading generic pharmaceutical company (Sandoz/Novartis subsidiary), supplying prescription generics to pharmacies and hospitals nationwide. Most direct head-to-head competitor for Ascend in the German off-patent generic market, with overlapping therapeutic categories and identical channel structure.
• Aurobindo Pharma Deutschland GmbH: Indian-headquartered generic pharmaceutical manufacturer with a German subsidiary supplying prescription generics across Europe. Closely comparable to Ascend in origin (Indian parent), product type (small-molecule generics), and customer base (German pharmacies and hospitals).
• KRKA Deutschland GmbH: Slovenian-headquartered generic pharmaceutical company with a dedicated German subsidiary supplying prescription generics to pharmacies and hospitals. Direct peer for Ascend in channel, customer base, and portfolio breadth across cardiovascular, CNS, and metabolic therapy areas.
• Heumann Pharma GmbH: German generic pharmaceutical company with a portfolio covering cardiovascular, neurology, and metabolic therapy areas. Direct competitor to Ascend in supplying prescription generics to German pharmacies and hospitals under reference pricing.
• ratiopharm GmbH: Long-established German generic pharmaceutical brand (Teva subsidiary) supplying prescription medicines across a broad therapeutic portfolio. Competes with Ascend for the same pharmacy and hospital formularies under German reference pricing.
• Zentiva Germany: European-focused generic pharmaceutical company with a strong German commercial presence supplying pharmacies and hospitals. Comparable to Ascend in target market, customer base, and product positioning around affordable off-patent prescription medicines.
• ALIUD PHARMA GmbH: German generic pharmaceutical company (STADA subsidiary) supplying a broad range of prescription generics to pharmacies. Competes head-to-head with Ascend in the same channel, with overlapping therapeutic coverage and similar positioning on price-competitive off-patent products.

Regional players

• Glenmark Pharmaceuticals Deutschland GmbH: Indian-headquartered generic and specialty pharmaceutical company with a German affiliate marketing prescription generics in Europe. Similar parent-subsidiary model and product positioning to Ascend, focused on affordable off-patent medicines across multiple therapy areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/ascend-gmbh-de

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascend GmbH